Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	1,001	1,113	871	1,568	1,773	2,692
Market Cap Growth	-13.10%	27.80%	-44.45%	-11.56%	-34.12%	3.08%
Enterprise Value	1,181	1,327	594.4	1,415	1,669	2,106
Last Close Price	24.72	25.88	18.84	33.74	38.61	60.17
PE Ratio	156.62	161.75	-8.76	37.91	113.56	65.40
Forward PE	9.39	7.53	7.10	10.23	11.64	15.43
PEG Ratio	-	0.66	0.66	0.66	0.66	0.66
PS Ratio	1.38	1.53	1.24	2.32	2.66	4.97
P/FCF Ratio	7.32	-	4.87	11.24	15.39	33.71
P/OCF Ratio	6.59	-	4.60	10.14	12.21	21.41
EV/Sales Ratio	1.63	1.83	0.85	2.10	2.50	3.89
EV/EBITDA Ratio	9.50	69.15	109.79	8.67	11.02	17.78
EV/EBIT Ratio	35.45	69.15	-8.10	16.14	27.81	23.42
EV/FCF Ratio	8.64	-	3.33	10.14	14.49	26.38
Debt / EBITDA Ratio	19.39	19.39	-	-	-	-
Net Debt / EBITDA Ratio	11.13	11.13	-51.12	-0.94	-0.69	-4.94
Net Debt / FCF Ratio	-	-	-1.55	-1.10	-0.90	-7.33
Asset Turnover	3.34	3.34	3.26	5.24	1.93	1.58
Return on Assets (ROA)	3.68%	3.68%	-53.83%	46.32%	20.82%	19.53%
Return on Capital Employed (ROCE)	8.82%	8.82%	-34.12%	68.11%	17.41%	26.23%
Earnings Yield	0.70%	0.62%	-11.41%	2.64%	0.88%	1.53%
FCF Yield	13.65%	0.00%	20.52%	8.89%	6.50%	2.97%
Buyback Yield / Dilution	2.60%	2.60%	11.03%	-11.69%	-1.99%	-4.46%
Total Shareholder Return	2.60%	2.60%	11.03%	-11.69%	-1.99%	-4.46%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q